免疫系统
癌症研究
间质细胞
体内
肿瘤微环境
靶向给药
癌细胞
细胞生物学
细胞培养
靶向治疗
化学
抗体调理
体外
细胞
内吞作用
补体系统
间充质干细胞
癌症
肝癌
生物
细胞毒性
药物输送
材料科学
免疫疗法
基因靶向
炎症
作者
David Angarita,Hanmant K. Gaikwad,David Siegel,Hanna Mattanovich,Aislinn Warmka,Joshua B. Judson,Kyle A. Sullivan,Elizabeth R. Woodruff,Fabian Villagomez,Tomomi M. Yamamoto,Jesse D. Hudspeth,Khoi L.M. Nguyen,Benjamin Guy Bitler,Kian Behbakht,Natalie J. Serkova,Alex J. Vecchio,John Janetzko,Thomas J. Anchordoquy,Gina Bouchard,Dmitri Simberg
出处
期刊:ACS Nano
[American Chemical Society]
日期:2026-11-19
标识
DOI:10.1021/acsnano.6c11570
摘要
Nanoparticles with targeting ligands can act as “magic bullets” to selectively target tumor cells, a concept that has captivated the drug delivery field for decades. Using cell culture, engineered mouse models, and spatial imaging, we studied how cellular interactions influence targeting of claudin-4 (CLDN4), a key ovarian cancer target. We coupled the C-terminal domain of Clostridium perfringens enterotoxin (cCPE), a high-affinity CLDN4 binder, to ∼60 nm dextran iron oxide nanoworms (CLIO NW) via click chemistry. Targeted NWs had nanomolar affinity for CLDN4 and specifically targeted CLDN4+ cells in culture and 3D spheroids. After systemic injection in mice, targeted NWs exhibited a long plasma half-life. In bilateral CLDN4+/CLDN4– xenograft tumors, targeted NWs accumulated more in CLDN4+ tumors but were also taken up by Kupffer cells in the liver and CD45+ immune cells in both tumors. Repeating the study with anti-CLDN4 IgG-decorated NWs, we again observed high in vitro specificity but low in vivo selectivity, as confirmed by optical and magnetic resonance imaging. Spatial proteomic analysis of tumors showed that NWs mainly accumulate in tumor cells, immune cells, and myofibroblasts, with tumor core cells mostly negative for NWs. Cell stress and metabolic profiles remain unchanged after the uptake. Coculture of CLDN4+ tumor cells and macrophages replicated the limited selectivity of targeted NWs in vivo and suggested that complement opsonization contributes to limited selectivity. Overall, stromal and immune uptake hinder CLDN4 targeting. Future efforts should focus on understanding and inhibiting nanoparticle uptake pathways to develop molecularly targeted nanomedicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI